Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.
Mosche PompschRoland VeltkampRolf R DiehlMarkus KraemerPublished in: Journal of neurology (2022)
APT is required in patients with MMA. MES monitoring may help to identify risk patients in need of intensified APT.